Adrenocortical hyperfunction associated with bronchogenic carcinoma: report of five cases.
Five patients with bronchogenic carcinoma associated with adrenocortical hyperfunction are described. The clinical features, laboratory studies and autopsy findings are discussed and compared with previously reported cases. Four patients presented most of the typical features of this disorder as previously described, whereas the fifth was atypical in some respects. Typical features included: acute onset of adrenocortical hyperfunction in a middle-aged male, rapid downhill course, slight or absent physical signs of Cushing's syndrome, frequently impaired glucose tolerance, markedly elevated plasma and urinary 17-hydroxycorticosteroids not suppressed by exogenous steroids, absent diurnal variation of plasma corticoids, hypokalemic alkalosis with normal aldosterone excretion, and tumour histology of the oat cell variety. The adrenal glands of two patients were of normal or slightly increased weight, and mean 17-ketosteroid excretion values were normal in three; this contrasts with the marked increase in adrenal weight and 17-ketosteroid excretion in most reported cases.
D015068:17-Ketosteroids; D000311:Adrenal Glands / Q000473:pathology*; D000308:Adrenocortical Hyperfunction; D000328:Adult; D000471:Alkalosis; D001344:Autopsy; D001769:Blood; D002283:Carcinoma, Bronchogenic / Q000150:complications*; D019411:Clinical Laboratory Techniques; D005951:Glucose Tolerance Test; D006801:Humans; D007008:Hypokalemia; D008175:Lung Neoplasms / Q000150:complications*; D008297:Male; D008875:Middle Aged; D014556:Urine
D015068:17-Ketosteroids
J Clin Endocrinol Metab. 1959 Aug;19:967-79
13843339
Metabolism. 1964 Sep;13:847-51
14231286
J Clin Endocrinol Metab. 1963 Jun;23:533-8
13975690
J Clin Endocrinol Metab. 1962 May;22:494-500
14449676
J Clin Endocrinol Metab. 1958 Nov;18(11):1285-95
13587645
Am J Med. 1963 Feb;34:192-212
13999999
Proc R Soc Med. 1953 Dec;46(12):1070-7
13120840
Ann Intern Med. 1964 Oct;61:733-56
14217138
Acta Endocrinol (Copenh). 1960 Sep;35:34-48
13718150
Am J Med. 1961 Oct;31:632-9
13873020
Lancet. 1960 Aug 6;2(7145):278-84
13792839
Presse Med. 1958 Mar 12;66(20):437-8
13542587
Guys Hosp Rep. 1952;101(4):251-72
12999049
Am J Med. 1962 Sep;33:398-407
14450347
Lancet. 1957 Jan 5;272(6958):23-5
13386268
Ann Intern Med. 1961 Jun;54:1295-300
13714383
Ann Intern Med. 1961 Jun;54:1248-59
13697346
J Biol Chem. 1950 Jul;185(1):201-7
15436491
Klin Wochenschr. 1962 Oct 1;40:1014
13938775
Dis Chest. 1953 Jun;23(6):621-33
13060182
Can Med Assoc J. 1965 Feb 13;92:317-24
14243867
Ann Intern Med. 1961 Jun;54:1243-8
13766951
J Clin Endocrinol Metab. 1963 Mar;23:293-300
13936721
Am J Med. 1952 Nov;13(5):597-614
12996538
Am J Med. 1958 Jun;24(6):981-8
13570643
J Clin Endocrinol Metab. 1960 Dec;20:1539-60
13761950
J Clin Endocrinol Metab. 1963 Mar;23:248-54
13993281
Lancet. 1963 Feb 16;1(7277):362-3
14023251
Lancet. 1962 Sep 15;2(7255):534-6
13920875
J Clin Endocrinol Metab. 1961 Nov;21:1413-25
14493561
AMA Arch Surg. 1956 Mar;72(3):495-9
13291976
Arch Intern Med. 1963 Apr;111:471-5
13930496
Lancet. 1960 Aug 6;2(7145):284-7
13795778
J Clin Endocrinol Metab. 1964 May;24:401-7
14169497
N Engl J Med. 1961 Nov 30;265:1083-8
13879332